Japan to ready 1m doses of coronavirus vaccine for swift distribution

AnGes-led team ramps up capacity while product is still under development

20200619N Takara Bio

Takara Bio will produce more precursors for AnGes's coronavirus vaccine. (Photo courtesy of Takara Bio)

KENYA AKAMA, Nikkei staff writer

KYOTO -- A team led by Japanese biotech venture AnGes will ready production capacity for 1 million doses of coronavirus vaccines by March, a fivefold increase from the original plan, in order to ensure swift access to the domestic population.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.